Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07781462

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07781462
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07781462. Randomized; double masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
Condition
Delirium in Intensive Care Unit
Condition
Acute Heart Failure (AHF)
Intervention (Drug)
Low dose ketamine infusion
Intervention (Drug)
Dexmedetomidine infusion
Lead sponsor
Alexandria University (class: other)

Record details

Record id
cardio:ct-nct07781462
Content hash
136bd7165f20c905474eb8bfe4e8fff1f61d5ee67a0f326dc357279f417a6867